PHARMACOKINETICS AND SAFETY OF THE ANTI-HUMAN CYTOMEGALOVIRUS DRUG LETERMOVIR IN SUBJECTS WITH HEPATIC IMPAIRMENT Article Kropeit D., McCormick D., Erb-Zohar K., Moiseev V.S., Kobalava Z.D., Stobernack H.-P., Zimmermann H., Rübsamen-Schaeff H. British Journal of Clinical Pharmacology. Blackwell Publishing Ltd. Vol. 83. 2017. P. 2678-2686
PHARMACOKINETICS OF SERELAXIN IN PATIENTS WITH HEPATIC IMPAIRMENT: A SINGLE-DOSE, OPEN-LABEL, PARALLEL GROUP STUDY Article Kobalava Z., Villevalde S., Kotovskaya Y., Hinrichsen H., Petersen-Sylla M., Zaehringer A., Pang Y., Rajman I., Canadi J., Dahlke M., Lloyd P., Halabi A. British Journal of Clinical Pharmacology. Blackwell Publishing Ltd. Vol. 79. 2015. P. 937-945
EFFECT OF LOCAL HYPERTHERMIA OF THE BLADDER ON MITOMYCIN C PHARMACOKINETICS DURING INTRAVESICAL CHEMOTHERAPY FOR THE TREATMENT OF SUPERFICIAL TRANSITIONAL CELL CARCINOMA Article Paroni Rita, Salonia Andrea, Lev Avigdor, Da Pozzo L.F., Cighetti Giuliana, Montorsi Francesco, Rigatti Patrizio, Colombo Renzo British Journal of Clinical Pharmacology. Blackwell Publishing Ltd. Vol. 52. 2001. P. 273-278